|
14 July 2003
Morphochem
website reflects companies transition
Northbank Communications
was commissioned by Morphochem, the trans-national evolutionary
drug discovery and development company, to design and copywrite
their new website. Morphochem urgently needed a new website that
successfully reflected its transition from a chemical technology
platform company to one that is generating products that are
approaching the clinic. The website followed other corporate
image projects including a new corporate presentation and new
factsheets.
Thomas Loeser, Morphochem's CFO, said "We are really
delighted with the professional look and dynamic feel of our new
website. The design and content clearly projects our successful
advancement in generating products both in house and for partners
in areas of unmet medical needs. The site is easy to navigate and
the content, which is easily updated, enables us to use it as an
effective business development tool. In addition investors will
rapidly be able to keep abreast of our corporate developments,
while potential collaborators can keep track of our scientific
endeavours. The site has a strong photographic element and all
images were taken at Morphochem. This strongly reflects the value
we place on our people".
He continued "It has been excellent working with the Northbank
team over the last 12 months to develop and promote Morphochem's
corporate image".
Sue Charles, CEO and
director in charge of the Morphochem account said "I have
worked with Morphochem on various communicatrions projects over
the past 5 years. I am pleased that our communications
efforts have helped position Morphochem prominently and reflect
their growth and success".
The web project direction was given by Sue Charles, creative work
was driven by Chris Fisher, and copywriting and project management
by Dr Eileen Paul.
The new website can be viewed at: www.morphochem.com
back
to news
|